COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey

NCT04389996 | Completed

• 1 other identifier: OP_1132
• Study Type: observational
• Target: 6,810
• Locations: 1 country
• Sites: 2

Brief Summary

The outbreak of coronavirus was categorized as a global pandemic in March 2020. The Danish government recommends social distancing during the COVID-19 pandemic. Long-term social distancing and fear of disease can lead to anxiety, depression and the feeling of loneliness. All these factors might affect the quality of life (QoL). The aim of this study is to investigate the overall QoL for patients with cancer during the COVID-19 pandemic with special focus on emotional functioning.

Conditions

Cancer

Keywords

Cancer; Quality of Life; COVID-19

Outcome Measures

Primary Outcomes (1)

• Overall Quality of Life

  EORTC (European Organisation for Research and Treatment of Cancer) QLQ-C30 (Quality of Life Questionnaire core 30) - The QLQ-C30 is a standardized cancer-specific 30-itemed instrument. Scores are transformed linearly to a zero to 100 scale. A higher score on the functional scale and the global Health related Quality of Life indicates better functioning. In the current study, the items addressing global quality of life and health: "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" will be used to get a pure expression of QoL. The EORTC QLQ-C30 scores in this study will be compared with QoL for Danish Cancer patients in the period before COVID-19 (https://www.cancer.dk/dyn/resources/File/file/3/8373/1574778638/kraeftens-bekaempelses-barometerundersoegelse-2019.pdf). Results on overall QoL is listed on page 36.

  One measurement of EORTC QLQ-C30 and a survey created for the purpose will be performed through study completion, an average of 1 months

Study Arms (1)

Patients with cancer

Survey

Other: No intervention

Interventions

No intervention OTHER

Patients will be sent a survey incl. EORTC QLQ-C30

Patients with cancer

Eligibility Criteria

• Age: 18 Years - 125 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients are recruited at the Department of Oncology and the Department of Haemotology, Odense University Hospital, Denmark. Patients are either receiving cancer treatment or in follow-up for a cancer diagnosis

You may qualify if:

• Patients with cancer
• Patients who are receiving cancer treatment or patients in follow-up for a cancer diagnosis
• Age 18+

You may not qualify if:

• Patients without "eBoks" - a secure electronic mailbox used to receive digital mail from the private sector

Sponsors & Collaborators

• Odense University Hospital: lead

Study Sites (2)

Department of Haemotology, Odense University Hospital

Odense, Region Syddanmark, 5000, Denmark

Location

Department of Oncology, Odense University Hospital

Odense C, 5000, Denmark

Location

MeSH Terms

Conditions

Neoplasms; COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Stefan S Jeppesen, MD, PhD

  Odense University Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head of Department of Oncology, Associate professor, PhD

Study Record Dates

• First Submitted: May 12, 2020
• First Posted: May 15, 2020
• Study Start: May 14, 2020
• Primary Completion: July 21, 2020
• Study Completion: July 21, 2021
• Last Updated: July 28, 2021

Record last verified: 2021-07

Locations

DK (2)